Our findings demonstrated that valproate treatment in glioblastoma T98G cells effectively reduced the mRNA levels of vimentin, alpha-SMA, and twist, while simultaneously increasing the expression of the epithelial protein E-cadherin. The gene discussed is CDH1; the disease is glioblastoma.